Meta-regression analyses revealed significant effects of illness duration, with higher S100B serum levels in the disorder’s course, and an impact of clinical symptomatology, in particular a negative correlation of the total score of the PANSS with serum S100B levels in schizophrenia. Here, S100B is linked to schizophrenia.